Why we can't 'boost' our way out of the COVID-19 pandemic for the long term
With yet another COVID-19 booster available for vulnerable populations in the U.S., many people find themselves wondering what the end game will be.
Apr 18, 2022
0
133
With yet another COVID-19 booster available for vulnerable populations in the U.S., many people find themselves wondering what the end game will be.
Apr 18, 2022
0
133
A new study has analyzed over 3000 proteins to identify which are causally linked to the development of severe COVID-19. This is the first study to assess such a large number of proteins for their connection to COVID-19. ...
Mar 3, 2022
0
267
Cancerous tumors are made up of rapidly growing, abnormally shaped, cells that can infiltrate and destroy healthy tissues, travel to other parts of the body, and form additional tumors. In part because of its rapid and invasive ...
Feb 7, 2022
0
36
Scientists at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) believe it may be possible to prevent DNA changes driven by two proteins highly active in leukemia and other cancers. They ...
Feb 4, 2022
0
68
Researchers at the Universities of Bonn and Regensburg have elucidated the structure of a central cellular inflammatory switch. Their work shows which site of the giant protein called NLRP3 inhibitors can bind to. This opens ...
Feb 3, 2022
0
105
In a new study, researchers at Karolinska Institutet have identified the presence of a specific connection between a protein and an lncRNA molecule in liver cancer. By increasing the presence of the lncRNA molecule, the fat ...
Jan 12, 2022
0
21
Many treatments for COVID-19 focus on the spike protein that the virus uses to bind to human cells. While those treatments work well on the original variant, they may not be as effective on future ones. The Omicron variant, ...
Jan 12, 2022
0
225
Researchers are a step closer to transforming a US$70 billion global diagnostic industry with new designer biosensors that 'switch on' color or electrical responses to drugs used in cancer, arthritis, and organ transplant ...
Dec 19, 2021
1
44
Scientists at St. Jude Children's Research Hospital have a new understanding of how a group of well-known fusion oncoproteins causes leukemia. The findings show the importance of liquid-liquid phase separation (LLPS), a process ...
Dec 13, 2021
0
1
A molecule that shows promise in preventing Parkinson's disease has been refined by scientists at the University of Bath in the UK, and has the potential to be developed into a drug to treat the deadly neurodegenerative disease.
Dec 9, 2021
0
290